Distinct risks of exacerbation and lung function decline between never-smokers and ever-smokers with COPD

被引:0
|
作者
Park, Heemoon [1 ]
Jo, Soo Min [2 ]
Jin, Kwang Nam [3 ]
Lee, Hyo Jin [1 ]
Lee, Hyun Woo [1 ]
Park, Tae Yun [1 ]
Heo, Eun Young [1 ]
Kim, Deog Kyeom [1 ]
Lee, Jung-Kyu [1 ]
机构
[1] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med,Seoul Metropolitan Govt, 20 Boramaero,5 Gil, Seoul 07061, South Korea
[2] Dongguk Univ, Ilsan Hosp, Dept Internal Med, Div Pulm & Crit Care Med,Seoul Metropolitan Govt, Goyang, South Korea
[3] Seoul Natl Univ, Boramae Med Ctr, Dept Radiol, Seoul Metropolitan Govt, Seoul, South Korea
来源
BMC PULMONARY MEDICINE | 2025年 / 25卷 / 01期
关键词
COPD; Never-smoker; Exacerbation; Lung function; OBSTRUCTIVE PULMONARY-DISEASE; POPULATION;
D O I
10.1186/s12890-025-03604-1
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BackgroundChronic obstructive pulmonary disease (COPD) can occur in patients without a history of smoking, which is a strong risk factor for COPD. However, few studies have focused on the prognosis of never-smokers with COPD. We investigated the difference of the longitudinal clinical outcomes between never-smokers and ever-smokers with COPD.MethodsWe retrospectively analyzed patients with COPD who underwent chest computed tomography and longitudinal lung function tests from January 2013 to December 2020. We classified patients according to smoking status and examined their histories of acute exacerbation and long-term changes in lung function.ResultsAmong 583 patients with COPD, 75 (12.9%) had no smoking history. These never-smokers with COPD were predominantly women; they had a lower forced vital capacity and a higher prevalence of asthma, history of tuberculosis, tuberculosis-destroyed lung, and bronchiectasis, but a lower prevalence of emphysema, relative to ever-smokers with COPD. Never-smokers with COPD had significantly lower risks of subsequent moderate to severe exacerbation (beta +/- standard error, - 0.4 +/- 0.12; P = 0.001), any exacerbation (adjusted odds ratio, 0.46; 95% confidence interval, 0.26 - 0.8; P = 0.006), and frequent exacerbation (adjusted odds ratio, 0.28; 95% confidence interval, 0.09 - 0.89; P = 0.03) than ever-smokers with COPD. Never-smokers with COPD also showed significantly slower annual decline of forced expiratory volume in 1 s than ever-smokers with COPD (- 15.7 +/- 4.7 vs. -30.4 +/- 2.9 mL, respectively; P = 0.03).ConclusionsNever-smokers with COPD had significantly fewer acute exacerbations and slower decline of lung function than ever-smokers with COPD during longitudinal follow-up.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Non-small cell lung cancer in ever-smokers vs never-smokers
    Burt, Jeremy R.
    Qaqish, Naim
    Stoddard, Greg
    Jridi, Amani
    Anderson, Parker Sage
    Woods, Lacey
    Newman, Anna
    Carter, Malorie R.
    Ellessy, Reham
    Chamberlin, Jordan
    Kabakus, Ismail
    BMC MEDICINE, 2025, 23 (01):
  • [2] Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study
    Tan, W. C.
    Sin, D. D.
    Bourbeau, J.
    Hernandez, P.
    Chapman, K. R.
    Cowie, R.
    FitzGerald, J. M.
    Marciniuk, D. D.
    Maltais, F.
    Buist, A. S.
    Road, J.
    Hogg, J. C.
    Kirby, M.
    Coxson, H.
    Hague, C.
    Leipsic, J.
    O'Donnell, D. E.
    Aaron, S. D.
    THORAX, 2015, 70 (09) : 822 - 829
  • [3] RISK FACTORS OF COPD IN NEVER-SMOKERS VS. EVER-SMOKERS FROM KOREAN NHANES
    Chang, Jung H.
    Ryu, Yon Ju
    Lee, Jin Hwa
    Lee, Seok Jeong
    RESPIROLOGY, 2013, 18 : 185 - 185
  • [4] The greater use of flavoured snus among ever-smokers versus never-smokers in Norway
    Tord Finne Vedoy
    Karl Erik Lund
    Harm Reduction Journal, 17
  • [5] The greater use of flavoured snus among ever-smokers versus never-smokers in Norway
    Vedoy, Tord Finne
    Lund, Karl Erik
    HARM REDUCTION JOURNAL, 2020, 17 (01)
  • [6] The Birmingham Chronic Obstructive Pulmonary Disease (COPD) Cohort Study: Preliminary Baseline Characteristics Of Ever-Smokers And Never-Smokers
    Enocson, A.
    Dickens, A. P.
    Jordan, R.
    Fitzmaurice, D.
    Adab
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [7] Among both men and women with COPD ever-smokers have higher disease burden and worse prognosis than never-smokers
    Lindberg, A.
    Szakacs, E.
    Stridsman, C.
    Sawalha, S.
    Nilsson, U.
    Hedman, L.
    Ronmark, E.
    Backman, H.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [8] Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokers
    Luo, Wenxin
    Zeng, Zhen
    Jin, Yang
    Yang, Lan
    Fan, Ting
    Wang, Zhoufeng
    Pan, Yitong
    Yang, Ying
    Yao, Menglin
    Li, Yangqian
    Xiao, Xue
    Wang, Gang
    Wang, Chengdi
    Chang, Shuai
    Che, Guowei
    Zhang, Li
    Li, Yalun
    Peng, Yong
    Li, Weimin
    CELL REPORTS MEDICINE, 2023, 4 (06)
  • [9] Genetic differences between smokers and never-smokers with lung cancer
    Kusnierczyk, Piotr
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [10] Pictorial Health Warnings on Cigarette Packages in Qatar: Preimplementation Awareness and Perceptions of Ever-Smokers Versus Never-Smokers
    Awaisu, Ahmed
    Hagi, Aisha
    Ashour, Marwa Attia
    Kheir, Nadir
    NICOTINE & TOBACCO RESEARCH, 2013, 15 (10) : 1765 - 1772